To determine the impact of CD9 Fab on the internalization of EVs by melanoma cells, we used engineered FEMX‐I cells to express the CD9‐GFP fusion protein.23 These cells release in vivo‐labelled fluorescent EVs that could be used to monitor EV uptake upon incubation with recipient cells. This evidence concerns the gene CD9 and melanoma.